Science Policy Committee
Howard McLeod, Pharm.D.
Executive Clinical Director, Precision Health
PMC's Science Policy Committee collaborates to develop and align medical practices and policies with the evolving base of evidence demonstrating the clinical and economic benefits of personalized medicine. The committee maintains two standing working groups focused on addressing clinical adoption challenges and improving value assessment frameworks.
» Science Policy
» Understanding and Delivering the Clinical and Economic Benefits of Personalized Medicine
Health Care Working Group
PMC’s Health Care Working Group provides a forum for the Coalition's members involved in health care delivery to discuss common challenges and potential solutions for integrating personalized medicine into clinical practice.
Value Assessment Framework Working Group
PMC’s Value Assessment Framework Working Group convenes members with interest or expertise in value assessment policies and practices. The group discusses challenges and strategies for appropriately accounting for personalized medicine in value and health technology assessments.